RecruitingNot ApplicableNCT07005063

Rotator Cuff Tendon Repair With FiberLocker System Patch Augmentation

Rotator Cuff Tendon Repair With FiberLocker System Patch Augmentation: A Prospective, Single-Arm, Non-Randomized, Pilot Study


Sponsor

ZuriMED Technologies AG

Enrollment

50 participants

Start Date

Jul 3, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

The overall objective of this clinical investigation is to assess the safety and efficacy of full-thickness arthroscopic rotator cuff repairs augmented with the FiberLocker System for the subjects. The primary outcome of the investigation is to assess the safety after full-thickness arthroscopic rotator cuff repairs augmented with the FiberLocker System in terms of postoperative adverse events through the 12-month follow-up. Main secondary outcomes include measures of efficacy and clinical performance evaluated at 6-week, 4.5-month, and 12-month follow-ups including retear rate assessed using MRI and different functional performance scores.


Eligibility

Min Age: 40 YearsMax Age: 65 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called FiberLocker® System (encompassing SpeedPatch® PET and FiberLocker Instrument® SN) for people with rotator cuff rupture, rotator cuff tear, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 40 Years to 65 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEFiberLocker® System (encompassing SpeedPatch® PET and FiberLocker Instrument® SN)

The FiberLocker® System is a mechanical augmentation system that includes an implant (SpeedPatch® PET) and an instrument (FiberLocker® Instrument SN) for its attachment. The implant is composed of non-woven PET fibers, and the instrument features a reciprocating needle at its tip, which pushes the individual patch fibers into the underlying tendon tissue


Locations(1)

Balgrist University Hospital

Zurich, Canton of Zurich, Switzerland

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07005063


Related Trials